pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
microbiotica PRESS RELEASE ARCHIVE
Apr 12, 2023
Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma
Nov 29, 2022
Microbiotica Announces Transition of Leadership
Mar 7, 2022
Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics
Jun 23, 2021
Microbiotica’s Live Bacterial Therapeutic, MB097, in development to begin clinical trials in 2022 in immuno-oncology
Jun 8, 2020
Microbiotica, Cancer Research UK and Cambridge University Hospitals Collaborate in Landmark Cancer Microbiome Study
Sep 25, 2019
Microbiotica Appoints Thomas Lynch as Independent Non-Executive Chairman
Jun 6, 2018
Microbiotica Enters into Microbiome Collaboration with Genentech
